What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more

How the FDA Weighs in on DNA Tests

December 29, 2013, 6:08 PM

Genomics is finding its way into the news increasingly and part of the reason for that, of course, is because genomics is becoming very relevant for medical care.  For example, the Food and Drug Administration - which oversees many of the things that come into clinical care - has gotten involved in a couple of ways. 

One of the things they did was to "clear" – in other words, approve the use of one of these fancy new methods for sequencing DNA for clinical use.  These new technologies that allow you to sequence a human genome very inexpensively – the FDA now has given clearance for its use under certain clinical situations.  And then similarly the FDA is carefully watching what’s going on with some genomic testing companies, in particular some companies that are called direct to consumer companies.  

These are companies where they don’t have a health care professional in the middle ordering the test.  Rather, consumers order it on themselves. They send in a little DNA sample by spitting in a tube and then genomic information about the individual is obtained and then given back to that individual. 

The FDA is establishing exactly what they want to be doing to make sure that this is done in an appropriate fashion.  And they sent out some warnings to one of the companies and are now interacting with them to make sure that they get the information that they need in order to make sure appropriate tests are being done and they’re appropriately validated and et cetera and so forth. 

I think we’re going to see a lot more of this because as genomics becomes relevant to medical care, regulatory agencies like the FDA are going to be watching this and making sure it’s being done properly. 

In Their Own Words is recorded in Big Think's studio.

Image courtesy of Shutterstock



How the FDA Weighs in on DN...

Newsletter: Share: